Skip to content

Under Armour UAA Short-term restricted investments

Short-term restricted investments at other companies

UroGen Pharma logo
UroGen PharmaURGN
$177K+0.6%
Intercontinental Exchange logo
Intercontinental ExchangeICE
$884M+43.3%
UFP Industries, Inc. logo
UFP Industries, Inc.UFPI
$51.3M+22.0%
Ingevity logo
IngevityNGVT
$24.7M
Construction Partners logo
Construction PartnersROAD
$16.15M-20.1%
Intercontinental Exchange logo
Intercontinental ExchangeICE
$70M+6.1%

Other financials

Income statement

See full
Revenue$1.2B-0.8%
Gross profit$492.0M-10.7%
Operating income-$33.7M+53.2%
Net income-$43.4M+35.7%
EPS (diluted)-$0.10+37.5%

Balance sheet

See full
Cash & equivalents$309.2M-40.0%
Total debt$1.9B+49.3%
Total equity$1.4B-25.2%
Total assets$4.4B+2.7%

Cash flow

See full
Operating cash flow-$332.2M-64.3%
CapEx$15.1M-47.6%
Free cash flow-$347.3M-50.3%

Valuation

See full
Market cap$2.46B-6.3%
Enterprise value$4.09B+19.5%
P/S0.5×0.0×

Profitability

See full
Gross margin45.5%-2.4pp
Operating margin-3.3%-0.3pp
Net margin-10%-27.8pp
FCF margin-3.3%-0.7pp

Returns & leverage

See full
Return on equity-30%-59.6pp
Debt / equity1.4×+0.7×
Current ratio1.6×-0.5×

Where this comes from

Reported directly by Under Armour in its filing.

Tagged under the XBRL concept us-gaap:RestrictedInvestmentsCurrent.

The official record: Under Armour’s 10-K, filed May 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Under Armour's short-term restricted investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Under Armour's short-term restricted investments?
Under Armour (UAA) reported short-term restricted investments of $605.4M in Q1 2026.